News

conference

Oct 23, 2023

2023 - ESMO

Phase 1 Clinical Results of SQ3370, a Doxorubicin-based Click Chemistry Therapeutic in Advanced Solid Tumor Patients

conference

Oct 16, 2023

2023 - World ADC

MMAE payload separated from HER2 targeting agent is selectively activated at tumors through click chemistry in vivo

media

Oct 12, 2023

Drug Discovery World

Click chemistry breakthroughs drive Shasqi and J&J cancer alliance

media

Oct 5, 2023

Drug Discovery World

Nobel-connected startup Shasqi deepens J&J partnership on CAPAC platform

press

Oct 4, 2023

Press release

Shasqi to Expand Existing Research Collaboration to Advance Targeted Cancer Treatment

press

Aug 2, 2023

Press Release

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team

media

Jul 5, 2023

Nature Biotech

Clicked' drugs: researchers prove the remarkable chemistry in humans

press

Jun 28, 2023

Press Release

Shasqi Publishes Data on Systemic Antigen Targeting Approach Using Click Chemistry to Activate MMAE in Tumors

publication

Jun 23, 2023

ACS Central Science

Click chemistry selectively activates an auristatin protodrug with either intratumoral or systemic tumor-targeting agents

conference

Jun 4, 2023

2023 - ISHAS

A Hyaluronate Derivative Biopolymer Enables Activation of Protodrugs at Tumors in Animals and Humans Using Click Chemistry

press

Jun 1, 2023

Press Release

Shasqi Announces Research Collaboration to Transform Targeted Cancer Treatment

media

Jun 1, 2023

SF Business Times

Click chemistry company Shasqi just struck a deal with Johnson & Johnson